$CERo Therapeutics (CERO.US)$ NASDAQ: CERO) announced FDA cl...

$CERo Therapeutics (CERO.US)$ NASDAQ: CERO) announced FDA clearance of its IND application for a Phase 1 trial of CER-1236, targeting acute myelogenous leukemia (AML). Shares closed up 59% at $0.3.

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) announced it will wind down operations and terminate employees following a special board meeting decision. Shares closed down 76% at $0.38.